2024
|
Invention
|
Method for visualizing at least a zone of an object in at least one interface.
The invention con... |
|
Invention
|
Novel nanoparticles of antiretroviral drugs, their preparation and their use for the treatment of... |
|
Invention
|
Anellovirus genome quantification as a biomarker of immune suppression.
The present invention re... |
|
Invention
|
Microfluidic device for studying and/or manipulating a study medium and/or at least one micro-obj... |
|
Invention
|
Single domain antibodies directed against human transmembrane- serine protease 2 (tmprss2). The i... |
|
Invention
|
Heterodimer of poxvirus a16 and g9 proteins as an immunogen. The invention relates to an isolated... |
|
Invention
|
Tumor specific antigens and uses thereof. The present invention relates to novel tumor specific p... |
|
Invention
|
Recombinant protein, expression cassette, immunogenic composition and use thereof. The present in... |
|
Invention
|
Method for identifying abnormalities in cells of interest in a biological sample. This invention ... |
|
Invention
|
Variants of terminal deoxynucleotidyl transferase and uses thereof.
The present invention relate... |
|
Invention
|
Combined antibodies against sarbecoviruses and uses thereof. The invention relates to combined an... |
|
Invention
|
Adeno-associated virus vector encoding connexin 26 and uses thereof. The present invention relate... |
|
Invention
|
Nucleic acid vaccine against the sars-cov-2 coronavirus. The invention relates to an immunogenic ... |
|
Invention
|
Antigenic tripeptides derived from mycobacterium avium subsp. paratuberculosis s-type strains, de... |
|
Invention
|
Antibodies against orthohantaviruses. Provided herein are hantivirus antibodies. These hantivirus... |
|
Invention
|
Optimized vector for delivery in microbial populations.
The present invention relates to a vecto... |
|
Invention
|
Bacteriophage therapy.
The subject invention provides a pharmaceutical composition comprising: (... |
|
Invention
|
Imidazopyrazine derivatives, process for preparation thereof, and their uses as luciferins.
The ... |
|
Invention
|
Potentiation of aminoglycosides through activation of carbohydrate transporters. The invention re... |
2023
|
Invention
|
Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurr... |
|
Invention
|
Variants of a dna polymerase of the polx family.
The invention relates to variants of a DNA poly... |
|
Invention
|
Generation of antibodies acting as silent and positive allosteric modulators of the alpha7 nicoti... |
|
Invention
|
Polynucleotides and lentiviral vectors expressing non-structural antigens of a flavivirus selecte... |
|
Invention
|
Acidic bacterial exopolysaccharide having immunopotentiating activity. The present invention rela... |
|
Invention
|
Antibodies that potently neutralize rabies virus and other lyssaviruses and uses thereof.
The in... |
|
Invention
|
Methods and systems for generating nucleic acid diversity in crispr-associated genes. Provided ar... |
|
Invention
|
Hsc70-4 in host-induced and spray-induced gene silencing. This disclosure provides proteins, DNA,... |
|
Invention
|
Lentiviral vectors for expression of human papillomavirus (hpv) antigens and its implementation i... |
|
Invention
|
Bacteriophage(s) targeting capsular deficient klebsiella pneumoniae (kp), compositions comprising... |
|
Invention
|
Benzamide adenine dinucleoside compounds and their uses. The inventors have now succeeded in deve... |
|
Invention
|
Method for detecting hpv infection in non-erosive lichen planus. The present invention relates to... |
|
Invention
|
Method for identifying abnormalities in cells of interest in a biological sample.
A computer-imp... |
|
Invention
|
Fc-engineered anti-human ige antibodies and methods of use.
The present invention relates to the... |
2022
|
Invention
|
Lentiviral vector for expression of human papillomavirus (hpv) antigens and its implementation in... |
|
Invention
|
Luminescent based antigen assay.
System for detecting an antigen comprising: —a first fusion pro... |
|
Invention
|
In vitro generation of organized 3d cell structures including head-trunk embryo-like structures, ... |
|
Invention
|
Single domain antibody specific for phosphorylated h2ax and its uses.
The present invention rela... |
|
Invention
|
Human neutralizing monoclonal antibodies against sars-cov-2 and uses thereof.
The invention rela... |
|
Invention
|
Mntbap and m(iii)n-substituted pyridylporphyrins(mnps)for use in reversing sepsis-induced microgl... |
|
Invention
|
Methods and systems for generating nucleic acid diversity.
Provided are methods comprising expre... |
|
Invention
|
Antimicrobial cationic peptoid and n-subtituted peptidic copolymers, preparation and uses thereof... |
|
Invention
|
Measles-hiv or measles-htlv vaccine.
The invention relates to recombinant measles virus expressi... |
2021
|
Invention
|
Biomarkers signature(s) for the prevention and early detection of gastric cancer.
The invention ... |
|
Invention
|
Gene therapy for treating usher syndrome.
The present invention proposes a gene therapy approach... |
|
Invention
|
Protected disaccharides, their process of preparation and their use in the synthesis of zwitterio... |
|
Invention
|
Optimal combination of early biomarkers for infection and sepsis diagnosis in emergency departmen... |
|
Invention
|
High throughput methods and products for sars-cov-2 sero-neutralization assay.
Pseudotyped lenti... |
|
Invention
|
Bacterial strains for use as probiotics, compositions thereof, deposited strains and method to id... |
2020
|
P/S
|
Scientific research instruments and apparatus for laboratories, namely, photographic equipment fo... |
|
P/S
|
Scientific research instruments and apparatus for
laboratories; downloadable computer software a... |
2019
|
P/S
|
Chemical and biological preparations and substances for
scientific and pharmaceutical industry; ... |
|
P/S
|
Chemical and biological preparations and substances intended
for science and the pharmaceutical ... |
2012
|
P/S
|
Vaccines for diseases notably cancer, AIDS, plague, rabies, malaria, hepatitis, dengue fever, flu... |
2009
|
P/S
|
Paper, cardboard and goods made from these materials, not
included in other classes, namely pack... |
2008
|
P/S
|
Paper, cardboard and goods made of these materials, not
included in other classes, namely packag... |
2000
|
P/S
|
Bleaching preparations and other substances for laundry use;
preparations for cleaning, polishin... |
1999
|
P/S
|
Chemicals used in industry, science, photography, as well as
in agriculture, horticulture and fo... |
1998
|
P/S
|
Préparations pharmaceutiques, nommément médicaments pour le traitement et la prévention de divers... |
|
P/S
|
Services éducatifs nommément, organisation et conduite de colloques, conférences, expositions et ... |
1993
|
P/S
|
periodical publications; namely, scientific journals, research reports and research activity repo... |
1987
|
P/S
|
Produits chimiques destinés à l'industrie, aux sciences. Produits pharmaceutiques, vétérinaires. |
1986
|
P/S
|
Heat-stable vaccine against yellow fever. |
|
P/S
|
Produits pharmaceutiques, vaccin et, plus particulièrement,
vaccin antigrippal. |
1984
|
P/S
|
Réactifs de laboratoires à usage biomédical. Produits pharmaceutiques et vétérinaires. |
1975
|
P/S
|
Produits chimiques destinés à l'industrie, la science, la
photographie, l'agriculture, l'horticu... |
1972
|
P/S
|
Préparations chimiques utilisées dans la fabrication pharmaceutique ou médicale ou réalisées dans... |
1970
|
P/S
|
Produits chimiques et compositions pour l'industrie
pharmaceutique, chimique, alimentaire, pour ... |